奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002755 奥赛康

已收盘 07-25 15:00:00

{"stockData":{"symbol":"002755","market":"SZ","secType":"STK","nameCN":"奥赛康","latestPrice":26.16,"timestamp":1753427037000,"preClose":26.92,"halted":0,"volume":18635730,"delay":0,"changeRate":-0.0282,"floatShares":927999999,"shares":927999999,"eps":0.1977,"marketStatus":"已收盘","change":-0.76,"latestTime":"07-25 15:00:00","open":26.81,"high":26.92,"low":25.9,"amount":490000000,"amplitude":0.0379,"askPrice":26.16,"askSize":16,"bidPrice":26.15,"bidSize":107,"shortable":0,"etf":0,"ttmEps":0.1977,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":26.92,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":29.61,"lowLimit":24.23,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":928160351,"isCdr":false,"pbRate":7.94,"roa":"--","peRate":132.3217,"roe":"1.76%","epsLYR":0.17,"committee":0.11838,"marketValue":24281000000,"turnoverRate":0.0201,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-07-28。","floatMarketCap":24280000000},"requestUrl":"/m/hq/s/002755","defaultTab":"news","newsList":[{"id":"2552455317","title":"单抗概念盘中拉升，奥赛康涨3.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552455317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552455317?lang=zh_cn&edition=full","pubTime":"2025-07-18 10:11","pubTimestamp":1752804674,"startTime":"0","endTime":"0","summary":"07月18日，单抗概念盘中拉升，截至10点11分，单抗概念整体指数上涨0.50%，报2613.400点。从个股上来看，该概念的成分股中，奥赛康涨3.63%，舒泰神、恒瑞医药、信立泰涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-3.01亿，其中恒瑞医药受到资金热捧，主力净流入1.22亿；拉长时间线来看，该板块近20日主力资金净流入25.13亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718101114a45242fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718101114a45242fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002755","BK0196","LU0405327494.USD","LU1328615791.USD","LU2328871848.SGD","BK0028","LU0405327148.USD","LU1997244956.HKD","LU1064130708.USD","LU1064131003.USD","BK0183","LU2495084118.USD","LU2488822045.USD","BK0239","LU1969619763.USD","BK0012","600276","LU1997245177.USD","BK0188","LU2148510915.USD","BK0060","LU1655091616.SGD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2552110213","title":"7月17日奥赛康现2笔折价12.52%的大宗交易 合计成交750.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552110213","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552110213?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:59","pubTimestamp":1752742748,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日奥赛康发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交3500.0手，折价成交2笔。该股近期无解禁股上市。截至2025年7月17日收盘，奥赛康报收于24.52元，上涨2.9%，换手率3.55%，成交量32.98万手，成交额7.99亿元。该股近半年内有股东持股变动，合计净减持2784.37万股，股东增减持明细如下表：该股最近90天内共有8家机构给出评级，买入评级6家，增持评级2家；过去90天内机构目标均价为23.87。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700026121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"gpt_icon":0},{"id":"2551149655","title":"7月16日奥赛康（002755）龙虎榜数据：机构净买入1.5亿元（3日），北向资金净买入2192.15万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2551149655","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551149655?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:13","pubTimestamp":1752657205,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年7月16日公布的交易公开信息显示，奥赛康因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月16日收盘，奥赛康报收于23.83元，上涨10.02%，已连续涨停2天，换手率4.54%，成交量42.17万手，成交额9.59亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入1.5亿元，北向资金合计净买入2192.15万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600027524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"gpt_icon":0},{"id":"2551011770","title":"异动快报：奥赛康（002755）7月16日14点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2551011770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551011770?lang=zh_cn&edition=full","pubTime":"2025-07-16 14:35","pubTimestamp":1752647721,"startTime":"0","endTime":"0","summary":"证券之星7月16日盘中消息，14点31分奥赛康触及涨停板。目前价格23.83，上涨10.02%。其所属行业化学制药目前上涨。领涨股为广生堂。该股为幽门螺杆菌概念，医药，创新药概念热股，当日幽门螺杆菌概念概念上涨2.26%，医药概念上涨1.43%，创新药概念上涨1.41%。7月16日的资金流向数据方面，主力资金净流出2513.62万元，占总成交额3.66%，游资资金净流入3783.11万元，占总成交额5.51%，散户资金净流出1269.49万元，占总成交额1.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600018379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"gpt_icon":0},{"id":"2551635132","title":"异动快报：奥赛康（002755）7月15日9点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2551635132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551635132?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:41","pubTimestamp":1752543663,"startTime":"0","endTime":"0","summary":"证券之星7月15日盘中消息，9点36分奥赛康（002755）触及涨停板。目前价格21.66，上涨10.01%。其所属行业化学制药目前下跌。领涨股为力生制药。该股为京津冀，幽门螺杆菌概念，医药概念热股。7月14日的资金流向数据方面，主力资金净流入2389.1万元，占总成交额9.94%，游资资金净流出2324.19万元，占总成交额9.67%，散户资金净流出64.91万元，占总成交额0.27%。近5日资金流向一览见下表：奥赛康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071500009282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"gpt_icon":0},{"id":"2551021029","title":"奥赛康：预计2025年1-6月归属净利润盈利1.35亿元至1.75亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551021029","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551021029?lang=zh_cn&edition=full","pubTime":"2025-07-14 18:07","pubTimestamp":1752487667,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康发布业绩预告，预计2025年1-6月归属净利润盈利1.35亿元至1.75亿元。奥赛康2025年一季报显示，公司主营收入5.09亿元，同比上升13.39%；归母净利润5473.03万元，同比上升73.5%；扣非净利润4399.72万元，同比上升86.93%；负债率24.09%，投资收益55.28万元，财务费用-287.58万元，毛利率82.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400029321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755"],"gpt_icon":0},{"id":"2549439985","title":"7月8日超级真菌概念上涨0.92%，板块个股联环药业、奥赛康涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2549439985","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549439985?lang=zh_cn&edition=full","pubTime":"2025-07-08 17:55","pubTimestamp":1751968542,"startTime":"0","endTime":"0","summary":"7月8日，截至收盘，超级真菌概念上涨0.92%，板块资金流入1.10亿。上涨个股家数16个，下跌个股家数3个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/08175551561434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0239","600513","002755"],"gpt_icon":0},{"id":"2548337251","title":"异动快报：奥赛康（002755）7月4日10点17分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2548337251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548337251?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:20","pubTimestamp":1751595633,"startTime":"0","endTime":"0","summary":"证券之星7月4日盘中消息，10点17分奥赛康触及涨停板。目前价格18.04，上涨10.0%。其所属行业化学制药目前上涨。领涨股为前沿生物。该股为创新药，幽门螺杆菌概念，医药概念热股，当日创新药概念上涨0.38%，幽门螺杆菌概念概念上涨0.18%，医药概念上涨0.11%。7月3日的资金流向数据方面，主力资金净流入2429.57万元，占总成交额9.46%，游资资金净流入607.36万元，占总成交额2.36%，散户资金净流出3036.94万元，占总成交额11.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400010553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"gpt_icon":0},{"id":"2546207232","title":"奥赛康收盘下跌4.48%，滚动市盈率79.77倍，总市值146.37亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546207232","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546207232?lang=zh_cn&edition=full","pubTime":"2025-06-26 16:56","pubTimestamp":1750928211,"startTime":"0","endTime":"0","summary":"6月26日，奥赛康今日收盘15.77元，下跌4.48%，滚动市盈率PE达到79.77倍，总市值146.37亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均52.89倍，行业中值30.70倍，奥赛康排名第122位。股东方面，截至2025年6月10日，奥赛康股东户数17382户，较上次增加87户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2025年一季报，公司实现营业收入5.09亿元，同比13.39%；净利润5473.03万元，同比73.50%，销售毛利率82.50%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/26165651322938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0028","002755"],"gpt_icon":0},{"id":"2545918494","title":"奥赛康最新公告：利厄替尼片III期临床研究结果发布于《柳叶刀·呼吸病学》","url":"https://stock-news.laohu8.com/highlight/detail?id=2545918494","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545918494?lang=zh_cn&edition=full","pubTime":"2025-06-23 17:16","pubTimestamp":1750670208,"startTime":"0","endTime":"0","summary":"奥赛康(002755.SZ)公告称，公司一类创新药利厄替尼片（奥壹新®）的III期临床研究结果已在国际顶级医学期刊《柳叶刀·呼吸病学》发布。利厄替尼片是第三代表皮生长因子受体（EGFR）酪氨酸激酶抑制剂（TKI），用于具有EGFR突变的局部晚期或转移性非小细胞肺癌（NSCLC）成人患者的一线、二线治疗。经IRC（独立影像评审委员会）评估，利厄替尼组中位PFS为20.7个月，显著优于对照组吉非替尼组的9.7个月，可有效降低疾病进展或死亡风险56%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300021269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"gpt_icon":0},{"id":"2545494566","title":"奥赛康(002755)6月10日股东户数1.74万户，较上期增加0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545494566","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545494566?lang=zh_cn&edition=full","pubTime":"2025-06-23 17:12","pubTimestamp":1750669923,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2025年6月10日公司股东户数为1.74万户，较5月31日增加87.0户，增幅为0.5%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至6月10日，化学制药行业平均股东户数为3.25万户。从股价来看，2025年5月31日至2025年6月10日，奥赛康区间跌幅为0.41%，在此期间股东户数增加87.0户，增幅为0.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300021046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"gpt_icon":0},{"id":"2545439451","title":"奥赛康(002755.SZ)子公司甲氨蝶呤注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2545439451","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545439451?lang=zh_cn&edition=full","pubTime":"2025-06-22 16:31","pubTimestamp":1750581065,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥赛康(002755.SZ)发布公告，公司的全资子公司江苏奥赛康药业有限公司于近日收到国家药品监督管理局(以下简称“药监局”)核准签发的甲氨蝶呤注射液《药品注册证书》。甲氨蝶呤是一种二氢叶酸还原酶抑制剂类药物，可干扰DNA合成、修复和细胞复制，具有广谱抗肿瘤活性，可单独使用治疗乳腺癌、妊娠性绒毛膜癌等，或与其它化疗药物联合使用治疗成骨肉瘤、急性白血病等，大剂量单独应用或与其它化疗药物联合应用治疗成骨肉瘤、急性白血病、支气管肺癌或头颈部表皮癌，以及用于银屑病化疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002755","BK0028"],"gpt_icon":0},{"id":"2544295133","title":"6月17日奥赛康跌6.35%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544295133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544295133?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:26","pubTimestamp":1750148809,"startTime":"0","endTime":"0","summary":"证券之星消息，6月17日奥赛康跌6.35%，收盘报16.8元，换手率2.02%，成交量18.78万手，成交额3.25亿元。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共34家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A目前规模为19.49亿元，最新净值1.649，较上一交易日下跌0.53%，近一年上涨59.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700024251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0028","BK1515","159938","BK1161","09939","BK0239","002755"],"gpt_icon":0},{"id":"2543374656","title":"每周股票复盘：奥赛康（002755）股东户数增加2340户，户均持股减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2543374656","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543374656?lang=zh_cn&edition=full","pubTime":"2025-06-14 04:04","pubTimestamp":1749845055,"startTime":"0","endTime":"0","summary":"本周关注点股本股东变化：截至2025年5月31日公司股东户数为1.73万户，较4月30日增加2340.0户公司公告汇总：2024年年度权益分派方案已获通过，向全体股东每10股派发现金红利1.20元股本股东变化近日奥赛康披露，截至2025年5月31日公司股东户数为1.73万户，较4月30日增加2340.0户，增幅为15.65%。公司公告汇总北京奥赛康药业股份有限公司2024年年度权益分派方案已获2025年5月29日召开的2024年年度股东大会审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400008147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"gpt_icon":0},{"id":"2542694455","title":"单抗概念盘中拉升，奥赛康涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2542694455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542694455?lang=zh_cn&edition=full","pubTime":"2025-06-12 13:17","pubTimestamp":1749705462,"startTime":"0","endTime":"0","summary":"06月12日，单抗概念盘中拉升，截至13点17分，单抗概念整体指数上涨2.00%，报2428.200点。从个股上来看，该概念的成分股中，奥赛康涨停，百济神州-U、长春高新等3只股涨幅超过5%。从资金上来看，截止发稿，单抗概念概念主力净流入为3.31亿，其中恒瑞医药受到资金热捧，主力净流入2.08亿；拉长时间线来看，该板块近20日主力资金净流入-31.13亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612131742a7049bf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612131742a7049bf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK0188","LU1328615791.USD","LU2148510915.USD","LU1064130708.USD","LU1064131003.USD","BK0239","01276","002755","LU0405327494.USD","688235","LU2328871848.SGD","LU0405327148.USD","BK0012","BK0060","BK0196","600276","BK0028","LU1969619763.USD","BK0183"],"gpt_icon":0},{"id":"2539221677","title":"奥赛康上涨5.7%，报17.44元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2539221677","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539221677?lang=zh_cn&edition=full","pubTime":"2025-05-30 10:54","pubTimestamp":1748573676,"startTime":"0","endTime":"0","summary":"5月30日，奥赛康盘中上涨5.7%，截至10:54，报17.44元/股，成交1.01亿元，换手率0.64%，总市值161.87亿元。截至2月28日，奥赛康股东户数1.66万，人均流通股5.59万股。2024年1月-9月，奥赛康实现营业收入13.84亿元，同比增长23.64%；归属净利润1.27亿元，同比增长168.79%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/30105450760190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0028","002755"],"gpt_icon":0},{"id":"2537510918","title":"5月22日奥赛康跌7.45%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537510918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537510918?lang=zh_cn&edition=full","pubTime":"2025-05-22 16:30","pubTimestamp":1747902659,"startTime":"0","endTime":"0","summary":"证券之星消息，5月22日奥赛康跌7.45%，收盘报17.03元，换手率1.31%，成交量12.13万手，成交额2.1亿元。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共34家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A目前规模为19.49亿元，最新净值1.4586，较上一交易日上涨2.04%，近一年上涨35.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200024641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","BK1574","BK0028","002755","BK1515","BK0239","09939"],"gpt_icon":0},{"id":"2535737519","title":"天风证券：给予奥赛康买入评级，目标价29.35元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535737519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535737519?lang=zh_cn&edition=full","pubTime":"2025-05-13 08:45","pubTimestamp":1747097128,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司杨松近期对奥赛康进行研究并发布了研究报告《创新转型成果初现，前药平台市场潜力可观》，给予奥赛康买入评级，目标价29.35元。　　奥赛康　　摘要：　　奥赛康主要聚焦于消化、肿瘤、耐药感染、慢性病4个治疗领域，截至2024年9月已有32个产品通过一致性评价，13个产品中标国采。奥赛康依托遮蔽肽平台，有望在实体瘤治疗领域形成差异化竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300005804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601162","002755"],"gpt_icon":0},{"id":"2534621874","title":"江苏奥赛康药业有限公司申请II类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2534621874","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534621874?lang=zh_cn&edition=full","pubTime":"2025-05-10 07:22","pubTimestamp":1746832978,"startTime":"0","endTime":"0","summary":"江苏奥赛康药业有限公司，成立于2003年，位于南京市，是一家以从事医药制造业为主的企业。通过天眼查大数据分析，江苏奥赛康药业有限公司共对外投资了13家企业，参与招投标项目3843次，知识产权方面有商标信息267条，专利信息340条，此外企业还拥有行政许可613个。主要股东信息显示，江苏奥赛康药业有限公司由北京奥赛康药业股份有限公司持股100%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/10072250281719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","002755","BK0239"],"gpt_icon":0},{"id":"2534775481","title":"奥赛康(002755)4月30日股东户数1.5万户，较上期增加0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534775481","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534775481?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:53","pubTimestamp":1746784439,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2025年4月30日公司股东户数为1.5万户，较4月20日增加130.0户，增幅为0.88%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至4月30日，化学制药行业平均股东户数为3.21万户。从股价来看，2025年4月20日至2025年4月30日，奥赛康区间涨幅为1.73%，在此期间股东户数增加130.0户，增幅为0.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900028607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753599268249,"stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.5845},{"period":"3month","weight":0.42},{"period":"6month","weight":0.845},{"period":"1year","weight":1.731},{"period":"ytd","weight":1.0714}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京奥赛康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17382人(较上一季度增加0.50%)","perCapita":"53397股","listingDate":"2015-05-15","address":"北京市丰台区南四环西路188号七区28号楼","registeredCapital":"92816万元","survey":"　　北京奥赛康药业股份有限公司的主营业务是原料药及制剂的研发、生产、销售。公司的主要产品是抗感染类、抗肿瘤类、慢性病类、消化类、其他类。奥赛康药业先后获得南京市市长质量奖、江苏省质量奖、全球卓越绩效奖（世界级）和中国质量奖提名奖，并获评江苏省质量信用AAA级企业、中国化学制药质量信用AAA级企业、中国医药质量管理奖、中国化学制药行业创新型优秀企业品牌、全国医药行业药品质量诚信建设示范企业、全国医药行业质量管理小组活动优秀企业等，深耕药品质量发展，坚持质量为先、品质为重。","listedPrice":7.49},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥赛康,002755,奥赛康股票,奥赛康股票老虎,奥赛康股票老虎国际,奥赛康行情,奥赛康股票行情,奥赛康股价,奥赛康股市,奥赛康股票价格,奥赛康股票交易,奥赛康股票购买,奥赛康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}